Pharmaceutical
Oragenics, Inc. today reported that it has closed on its previously announced equity financing of $2,600,000. As a result of the closing, the Company will issue 5,777,778 shares of common stock and warrants to acquire 5,777,778 million shares of common s
04:00 Jun 13, 2008
New data from a large, international clinical trial find that patients with newly diagnosed chronic myeloid leukemia who received Gleevec tablets at 800 mg/day as their initial treatment achieved clinical milestones significantly faster than those receiv
03:03 Jun 13, 2008
Car racing runs in the Petty family, handed down from NASCAR great Lee to his son Richard and grandson Kyle. But like too many American families, so does prostate cancer. To encourage prostate cancer screening and if diagnosed, to assemble a multidiscipl
03:03 Jun 13, 2008
New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta once daily experienced significant pain reduction. Patients taking duloxetine reported significant pain improvement compared to placebo within the
03:03 Jun 13, 2008
PAL Health Technologies will debut the new Xtremityscan System and give away a free unit at the Western Podiatric Medical Conference inAnaheim, California, June 19-22 at the Disneyland Hotel.
03:03 Jun 13, 2008
Cytokinetics, Incorporated announced results from three Phase I clinical trials evaluating CK-1827452, a novel cardiac myosin activator, in healthy subjects. One study was designed to investigate the potential for drug-drug interactions with CK-1827452,
02:30 Jun 13, 2008
achieved significant improvements in signs and symptoms when treated with Roche's ACTEMRA alone or in combination with methotrexate compared with methotrexate alone, according to two international Phase III studies presented by researchers at the Europea
02:23 Jun 13, 2008
NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
02:03 Jun 13, 2008
EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns, President and Chief Executive Officer, will present a Company overview during the B
02:03 Jun 13, 2008
The Blinded American Veterans Foundation , at its June 14 picnic inSilver Spring, MD, will honor Maryland State Delegate Sheila Hixson.
02:03 Jun 13, 2008
On Thursday, June 19, 2008, at 7:00 PM Central European Time/1:00 PM Eastern Time/10:00 AM Pacific Time members of Cell Therapeutics, Inc.'s management team will host a Special Meeting in lieu of the Annual Meeting of Shareholders at itsSeattle headquart
02:03 Jun 13, 2008
PAREXEL International Corporation , a leading global biopharmaceutical services organization, today announced that the Boards of PAREXEL International and ClinPhone plc, a company traded on the London Stock Exchange, have reached agreement on the terms o
02:03 Jun 13, 2008
According to Narconon Trois-Rivieres, drug addiction is not a random coincidence. The onset of drug addiction may be caused in most instances by a problem, a particular discomfort, an emotional disturbance or physical pain that the individual cannot hand
01:33 Jun 13, 2008
Roche announced today that its new test for detection of Chlamydia trachomatis has received CE Mark certification, allowing it to be sold for clinical use in the European Union. It is designed with a dual target approach to help ensure reliability of tes
01:03 Jun 13, 2008
VION PHARMACEUTICALS, INC. today announced that data from a previously conducted Phase II trial of its lead anticancer agent Cloretazine in elderly patients with acute myelogenous leukemia and high-risk myelodysplastic syndromes had been presented at the
22:33 Jun 12, 2008
73715 - 73729 of 82850 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
Daily News
